Hereditary and Inflammatory Cardiomyopathies

Coordinators: Pilar Martín Fernández

Organization: Centro Nacional de Investigaciones Cardiovasculares (CNIC)

Center: CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES (CNIC)

Pablo García Pavía Organization: Servicio Madrileño de Salud

Center: HOSPITAL UNIVERSITARIO PUERTA DE HIERRO

The Hereditary and Inflammatory Cardiomyopathies Program aims to coordinate basic and clinical research efforts to enhance the understanding of genetic and inflammatory heart muscle diseases, with the ultimate goal of improving their diagnosis and treatment. The program is structured around two main lines of research:

1. Hereditary Cardiomyopathies: Focused on identifying novel genetic bases and molecular mechanisms involved in these conditions to optimize diagnostic and therapeutic strategies. In 2024, the program will prioritize advancing the genetic characterization of patient cohorts, developing experimental models, and evaluating new targeted therapies.

2. Inflammatory Cardiomyopathy: Dedicated to investigating the mechanisms responsible for myocardial damage in the context of inflammation, including viral, autoimmune, and toxin-induced myocarditis. In 2024, efforts will concentrate on identifying diagnostic and prognostic biomarkers, and studying the role of the immune response in disease progression.

This program remains committed to translating scientific knowledge into effective clinical solutions for patients with hereditary and inflammatory cardiomyopathies